Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

RxSight (RXST) Accumulated Depreciation & Amortization (2020 - 2025)

RxSight's Accumulated Depreciation & Amortization history spans 6 years, with the latest figure at $3.3 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 8.33% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, down 8.33%, while the annual FY2025 figure was $3.3 million, 8.33% down from the prior year.
  • Accumulated Depreciation & Amortization reached $3.3 million in Q4 2025 per RXST's latest filing, down from $3.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.1 million in Q4 2023 to a low of $3.3 million in Q4 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.8 million, with a median of $3.9 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 5.13% in 2023, then fell 12.2% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $4.0 million in 2021, then fell by 2.5% to $3.9 million in 2022, then increased by 5.13% to $4.1 million in 2023, then fell by 12.2% to $3.6 million in 2024, then decreased by 8.33% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Accumulated Depreciation & Amortization are $3.3 million (Q4 2025), $3.6 million (Q4 2024), and $4.1 million (Q4 2023).